STOCK TITAN

Equillium: RA Capital reports 9.9% ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

RA Capital Management, L.P., its managers Peter Kolchinsky and Rajeev Shah, and RA Capital Healthcare Fund, L.P. each report beneficial ownership of 6,712,479 Equillium, Inc. (EQ) common shares, or 9.9%, as of September 30, 2026. The cover pages attribute shared voting and dispositive power over that amount.

The Fund directly holds 2,317,741 common shares and pre-funded warrants exercisable for up to 17,698,593 shares. A blocker limits exercise if ownership by the Fund, its affiliates and other attribution parties would exceed 9.9%; the Fund is also currently prohibited from exercising to the extent it would raise the reporting persons’ beneficial ownership above 6,712,479 shares. The Fund delegated voting and disposition power to RA Capital and disclaims beneficial ownership for Section 13(d) purposes.

Reported beneficial ownership 6,712,479 shares Reported by each reporting person as of September 30, 2026
Reported ownership percentage 9.9% Reported by each reporting person as of September 30, 2026
Fund-held common shares 2,317,741 shares Directly held by RA Capital Healthcare Fund, L.P.
Pre-funded warrants Up to 17,698,593 underlying shares Warrants held directly by RA Capital Healthcare Fund, L.P.
Common shares outstanding 63,408,082 shares Equillium shares outstanding as of August 7, 2026; the reported ownership percentage also gives effect to warrants exercisable within 60 days
Delegation revocation notice 61 days The Fund may not revoke its delegation of voting and investment power on less than 61 days’ notice
Pre-Funded Warrants technical
"Pre-Funded Warrants exercisable for up to 17,698,593 shares"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Beneficial Ownership Blocker regulatory
"the “Beneficial Ownership Blocker” which precludes exercise"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
beneficial ownership regulatory
"aggregate number of shares of common stock beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 13(d) regulatory
"for purposes of Section 13(d) of the Act"
A Section 13(d) filing is a public disclosure required under U.S. securities law when a person or group acquires more than 5% of a company’s registered equity and may influence control. The filer must report who owns the shares, how they were acquired, and any plans or intentions for the company, so the market and other shareholders can see if a large buyer is attempting a takeover or other strategic move. Think of it like a formal announcement that someone has crossed a threshold and is showing their hand.
shared dispositive power regulatory
"Shared Dispositive Power 6,712,479.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EQ shares do the reporting persons beneficially own?

Each of the four reporting persons reports beneficial ownership of 6,712,479 Equillium common shares, or 9.9%, as of September 30, 2026. The cover pages attribute shared voting and dispositive power over that reported amount.

What limits exercise of EQ pre-funded warrants?

RA Capital Healthcare Fund, L.P. holds pre-funded warrants exercisable for up to 17,698,593 shares. The warrants preclude exercise to the extent the Fund, together with its affiliates and other attribution parties, would own more than 9.9% of common stock outstanding. The Fund is currently prohibited from exercising to the extent it would cause the reporting persons’ beneficial ownership to exceed 6,712,479 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





29446K106

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RA Capital Management, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By Peter Kolchinsky, Authorized Signatory
Date:11/16/2026
Peter Kolchinsky
Signature:/s/ Peter Kolchinsky
Name/Title:Peter Kolchinsky
Date:11/16/2026
Rajeev Shah
Signature:/s/ Rajeev Shah
Name/Title:Rajeev Shah
Date:11/16/2026
RA Capital Healthcare Fund, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on March 20, 2026).

Keep reading